Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Franklin RA, Montalto G, Cervello M, Libra M, Candido S, Malaponte G, Mazzarino MC, Fagone P, Nicoletti F, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Chiarini F, Evangelisti C, Cocco L, Martelli AM.
McCubrey JA, et al. Among authors: evangelisti c.
Oncotarget. 2012 Oct;3(10):1068-111. doi: 10.18632/oncotarget.659.
Oncotarget. 2012.
PMID: 23085539
Free PMC article.
Review.